Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Clene Inc. Filed by: Ugwumba Chidozie

May 14, 2026 5:18 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: With regard to the number of shares reported in response to (5), (7), and (9) above, the number represents (i) 741,292 shares of Common Stock of the Issuer, (ii) 375,000 shares of Common Stock issuable upon exercise of Tranche A Warrants that are immediately exercisable, (iii) 375,000 shares of Common Stock issuable upon exercise of Tranche B Warrants that are immediately exercisable, and (iv) 424,358 shares of Common Stock issuable upon exercise of the Common Stock Purchase Warrant that is immediately exercisable. The foregoing is based on 11,778,307 shares of the Issuer's Common Stock issued and outstanding, as represented in the Issuer's Prospectus Supplement on Form 424(b)(5) filed with the Securities and Exchange Commission on January 9, 2026


SCHEDULE 13G



Ugwumba Chidozie
Signature:/s/ Chidozie Ugwumba
Name/Title:Reporting Person
Date:05/14/2026

Categories

SEC Filings